Central sleep apnea (CSA) in patients with heart failure (HF) occurs frequently and shows a serious influence on prognosis in this population. The key elements in the pathophysiology of CSA are respiratory instability with chronic hyperventilation, changes of arterial carbon dioxide pressure (pCO(2)) and elongated circulation time. The main manifestation of CSA in patients with HF is Cheyne-Stokes Respiration (CSR). The initial treatment is the optimization of HF therapy. However, many other options of the therapeutic management have been studied, particularly those based on positive airway pressure methods. In patients with heart failure we often can observe the overlap of CSA and CSR; we will discuss the differences between these forms of breathing disorders during sleep. We will also discuss when CSA and CSR occur independently of each other and the importance of CSR occurring during the daytime in context of CSA during the nighttime. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
机构:
Univ Michigan Hlth Syst, Dept Neurol, Michael S Aldrich Sleep Disorders Ctr, Ann Arbor, MI USAUniv Michigan Hlth Syst, Dept Neurol, Michael S Aldrich Sleep Disorders Ctr, Ann Arbor, MI USA
Sachdeva, Alok
Dunn, Abbey E.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan Hlth Syst, Dept Neurol, Michael S Aldrich Sleep Disorders Ctr, Ann Arbor, MI USAUniv Michigan Hlth Syst, Dept Neurol, Michael S Aldrich Sleep Disorders Ctr, Ann Arbor, MI USA
Dunn, Abbey E.
Kaplish, Neeraj
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan Hlth Syst, Dept Neurol, Michael S Aldrich Sleep Disorders Ctr, Ann Arbor, MI USAUniv Michigan Hlth Syst, Dept Neurol, Michael S Aldrich Sleep Disorders Ctr, Ann Arbor, MI USA
机构:
Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, Saitama 3308503, JapanJichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, Saitama 3308503, Japan